Get the Stockscreener App
0.00
100.00%
-7.59
Trxade Health Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$7.59
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$12.74M
Revenue:
$7.15M
Net Income/Loss:
$4.03M
P/E Ratio:
0.00
EPS:
-5.4
Net Cash Flow:
$-11.33M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$44.56
Trxade Health Inc Stock (MEDS) Company Profile
Name
Trxade Health Inc
Sector
Industry
Phone
(800) 261 0281
Address
2420 BRUNELLO TRACE, LUTZ, FL
Compare MEDS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDS
Trxade Health Inc
|
0.00 | 12.74M | 7.15M | 4.03M | -11.33M | -5.40 |
|
WBA
Walgreens Boots Alliance Inc
|
12.16 | 10.58B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
3.13 | 249.29M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
4.99 | 100.84M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
SCNX
Scienture Holdings Inc
|
3.9645 | 36.14M | 0 | 0 | 0 | 0.00 |
|
CJJD
China Jo Jo Drugstores Inc
|
1.89 | 11.99M | 148.81M | -21.14M | 0 | -0.9969 |
Trxade Health Inc Stock (MEDS) Latest News
TRxADE HEALTH (NASDAQ:MEDS) Trading Down 7% – What’s Next? - Defense World
TRxADE HEALTH (NASDAQ:MEDS) Stock Price Down 7% – What’s Next? - Defense World
TRxADE HEALTH (NASDAQ:MEDS) Trading 2.8% Higher – What’s Next? - Defense World
Scienture Holdings to Present at Microcap Conference 2025: Strategic Growth Plans in Focus - StockTitan
Trxade Group, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
Trxade Group, Inc. acquired Community Specialty Pharmacy, LLC from Nikul Panchal for $0.6 million. - Marketscreener.com
Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - StockTitan
Scienture Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
(SCNX) On The My Stocks Page - Stock Traders Daily
Gajan A. Mahendiran and Amudha Mahendiran acquired Westminster Pharmaceutical LLC from Trxade Group, Inc. for $1.6 million. - Marketscreener.com
Scienture Holdings Unveils New Identity Post-Merger - TipRanks
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - ForexTV.com
TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - ForexTV.com
Trxade Health announces name change to Scienture Holdings - TipRanks
Long Term Trading Analysis for (MEDS) - Stock Traders Daily
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
Trxade Health appoints Mani as President, Hariharan as CEO of Scienture - TipRanks
MEDS Earnings: A snapshot of Trxade’s Q2 2024 results - AlphaStreet
Virtu Financial LLC Buys New Shares in TRxADE HEALTH, Inc. (NASDAQ:MEDS) - Defense World
When the Price of (MEDS) Talks, People Listen - Stock Traders Daily
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team - StockTitan
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings - TipRanks
Closing Figures: Trxade Health Inc (MEDS)’s Positive Finish at 12.79, Up 9.97 - The Dwinnex
Company’s Banking Shares: Up -53.93% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
How To Trade (MEDS) - Stock Traders Daily
Surge In TRxADE (MEDS) Shares Following Business Combination Announcement - News IMC
Trxade Health closes business combination with Scienture in $103Mln deal - AlphaStreet
TRxADE Shares Surge on Scienture Merger - MarketWatch
$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com
TRxADE Health Merges with Scienture in $103M Deal - MarketWatch
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - ForexTV.com
Key Inflation data, 3M reports, and Bristol Myers report: Yahoo Finance - Head Topics
Trxade Health acquires Scienture in all-stock transaction valued at $103M - TipRanks
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
Trxade Health announces special cash dividend of $1.50 per share - TipRanks
TRxADE HEALTH, Inc. (MEDS) To Go Ex-Dividend on July 19th - Defense World
Janney Montgomery Scott LLC Purchases 10,099 Shares of AppLovin Co. (NASDAQ:APP) - Defense World
Shopify (TSE:SHO) Lifted to “Strong-Buy” at Wolfe Research - Defense World
(MEDS) Trading Report - Stock Traders Daily
TRxADE Health, Inc. Announces Special Cash Dividend - StockTitan
LVW Advisors LLC Has $458,000 Position in Best Buy Co., Inc. (NYSE:BBY) - Defense World
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan
MEDS Stock Earnings: Trxade Health Reported Results for Q1 2024 - InvestorPlace
TRxADE Health appoints new board member Subbarao Jayanthi - Investing.com
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
PACS Group gears up for $400 million IPO. Here’s all you need to know - AlphaStreet
Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Benzinga
Trxade Health Inc Stock (MEDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.54%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):